Treatment Information


Ovarian Cancer treatment details. Chemotherapy.

University of Arizona Cancer Center, Tucson, AZ, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Tucson, AZ
Treatments:ChemotherapyHospital:University of Arizona Cancer Center
Date:Mar 2004


Patients: This phase II study involved 97 women with stage III epithelial ovarian cancer.

Treatment: The treatment consisted of a chemotherapy drug called altretamine.

Toxicity: Grade 4 toxicities included neutropenia and anxiety/depression.

Results: Median survival was 57 months.

Support: The study was supported by a grant from MedImmune. This company manufactures or markets altretamine.

Correspondence: David S. Alberts, MD